4//SEC Filing
SANDS ARTHUR T 4
Accession 0001127602-13-008839
CIK 0001062822other
Filed
Feb 28, 7:00 PM ET
Accepted
Mar 1, 5:27 PM ET
Size
13.5 KB
Accession
0001127602-13-008839
Insider Transaction Report
Form 4
SANDS ARTHUR T
DirectorPres & CEO
Transactions
- Tax Payment
Common Stock
2013-02-28$1.98/sh−20,034$39,667→ 942,870 total - Exercise/Conversion
Restricted Stock Units (Phantom Stock)
2013-02-28−37,000→ 111,000 total→ Common Stock (37,000 underlying) - Exercise/Conversion
Common Stock
2013-02-28+36,250→ 925,904 total - Exercise/Conversion
Common Stock
2013-02-28+37,000→ 962,904 total - Exercise/Conversion
Restricted Stock Units (Phantom Stock)
2013-02-28−36,250→ 72,500 total→ Common Stock (36,250 underlying)
Holdings
- 817,500(indirect: By Sands Associates L.P.)
Common Stock
- 60,000(indirect: By Spouse)
Common Stock
Footnotes (4)
- [F1]Each restricted stock unit represents a contingent right to receive one share of common stock.
- [F2]Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto.
- [F3]Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2012 and vest an additional 25% on February 28 of each of the three succeeding years thereafter.
- [F4]Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2013 and vest an additional 25% on February 28 of each of the three succeeding years thereafter.
Documents
Issuer
LEXICON PHARMACEUTICALS, INC./DE
CIK 0001062822
Entity typeother
Related Parties
1- filerCIK 0001134106
Filing Metadata
- Form type
- 4
- Filed
- Feb 28, 7:00 PM ET
- Accepted
- Mar 1, 5:27 PM ET
- Size
- 13.5 KB